Search

Author/Creator Schumann, Christian

1. A randomized, phase 2 evaluation of the CHK1 inhibitor, LY2603618, administered in combination with pemetrexed and cisplatin in patients with advanced nonsquamous non‐small cell lung cancer. (June 2017)

Authors:
Wehler, Thomas; Thomas, Michael; Schumann, Christian; Bosch-Barrera, Joaquim; Viñolas Segarra, Nuria; Dickgreber, Nicolas J.; Dalhoff, Klaus; Sebastian, Martin; Corral Jaime, Jesus; Alonso, Miriam; Hynes, Scott M.; Lin, Ji; Hurt, Karla; Bence Lin, Aimee; Calvo, Emiliano; Paz-Ares, Luis
Journal:
Lung cancer
Issue:
Volume 108(2017)
Page Start:
212
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Ablation zone geometry after CT-guided hepatic microwave ablation: evaluation of a semi-automatic software and comparison of two different ablation systems. (1st January 2020)

Authors:
Vo Chieu, Van Dai; Wacker, Frank; Rieder, Christian; Pöhler, Gesa H.; Schumann, Christian; Ballhausen, Hanne; Ringe, Kristina I.
Journal:
International journal of hyperthermia
Issue:
Volume 37:Number 1(2020)
Page Start:
533
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Afatinib in Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations Pretreated With Reversible EGFR Inhibitors. (9th September 2015)

Authors:
Heigener, David F.; Schumann, Christian; Sebastian, Martin; Sadjadian, Parvis; Stehle, Ingo; Märten, Angela; Lüers, Anne; Griesinger, Frank; Scheffler, Matthias
Other Names:
Abdollahi A. contributionsBy.; Ammon A. contributionsBy.; Aries S.P. contributionsBy.; Arntzen C. contributionsBy.; Achenbach H.J. contributionsBy.; Atanackovic D. contributionsBy.; Atmaca A. contributionsBy.; Basara N. contributionsBy.; Binder D. contributionsBy.; Borchard B. contributionsBy.; B...
Journal:
Oncologist
Issue:
Volume 20:Number 10(2015)
Page Start:
1167
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Afatinib in Non‐Small Cell Lung Cancer Harboring Uncommon EGFR Mutations Pretreated With Reversible EGFR Inhibitors. (9th September 2015)

Authors:
Heigener, David F.; Schumann, Christian; Sebastian, Martin; Sadjadian, Parvis; Stehle, Ingo; Märten, Angela; Lüers, Anne; Griesinger, Frank; Scheffler, Matthias
Other Names:
Abdollahi A. contributionsBy.; Ammon A. contributionsBy.; Aries S.P. contributionsBy.; Arntzen C. contributionsBy.; Achenbach H.J. contributionsBy.; Atanackovic D. contributionsBy.; Atmaca A. contributionsBy.; Basara N. contributionsBy.; Binder D. contributionsBy.; Borchard B. contributionsBy.; B...
Journal:
Oncologist
Issue:
Volume 20:Number 10(2015)
Page Start:
1167
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Computed tomographic airway morphology after targeted lung denervation treatment in COPD. (January 2023)

Authors:
Hartman, Jorine E.; Herth, Felix J.F.; Shah, Pallav; Pison, Christophe; Valipour, Arschang; Slebos, Dirk-Jan; Valipour, Arschang; Abele, Christine; Firlinger, Irene; Kothakuzhakal, Kiran; Duller, Marina; Lamprecht, Bernd; Kropfmueller, Roland; Holzmann, Kornelia; Rathmeier, Sandra; Hubner, Ralf; ...
Journal:
Respiratory medicine
Issue:
Volume 206(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Dosing to rash? – The role of erlotinib metabolic ratio from patient serum in the search of predictive biomarkers for EGFR inhibitor-mediated skin rash. (March 2016)

Authors:
Steffens, Michael; Paul, Tanusree; Hichert, Vivien; Scholl, Catharina; von Mallek, Dirk; Stelzer, Christoph; Sörgel, Fritz; Reiser, Bärbel; Schumann, Christian; Rüdiger, Stefan; Boeck, Stefan; Heinemann, Volker; Kächele, Volker; Seufferlein, Thomas; Stingl, Julia
Journal:
European journal of cancer
Issue:
Volume 55(2016)
Page Start:
131
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Durvalumab after definitive chemoradiotherapy in locally advanced unresectable non-small cell lung cancer (NSCLC): Real-world data on survival and safety from the German expanded-access program (EAP). (December 2020)

Authors:
Faehling, Martin; Schumann, Christian; Christopoulos, Petros; Hoffknecht, Petra; Alt, Jürgen; Horn, Marlitt; Eisenmann, Stephan; Schlenska-Lange, Anke; Schütt, Philipp; Steger, Felix; Brückl, Wolfgang M.; Christoph, Daniel C.
Journal:
Lung cancer
Issue:
Volume 150(2020)
Page Start:
114
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. High-throughput screening identified inherited genetic variations in the EGFR pathway contributing to skin toxicity of EGFR inhibitors. (September 2015)

Authors:
Hasheminasab, Sayed-Mohammad; Tzvetkov, Mladen V; Schumann, Christian; Rüdiger, Stefan; Boeck, Stefan; Heinemann, Volker; Kächele, Volker; Steffens, Michael; Scholl, Catharina; Hichert, Vivien; Seufferlein, Thomas; Brockmöller, Jürgen; Stingl, Julia C
Journal:
Pharmacogenomics
Issue:
Volume 16:Number 14(2015)
Page Start:
1605
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. HLA polymorphisms influence the development of skin rash arising from treatment with EGF receptor inhibitors. (October 2012)

Authors:
Fuerst, Daniel; Parmar, Sumit; Schumann, Christian; Rüdiger, Stefan; Boeck, Stefan; Heinemann, Volker; Kaechele, Volker; Stiebel, Kristina; Paul, Tanusree; Seufferlein, Thomas; Mytilineos, Joannis; Stingl, Julia Carolin
Journal:
Pharmacogenomics
Issue:
Volume 13:Number 13(2012)
Page Start:
1469
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗